Abstract
In this viewpoint article, we review the current evidence for the efficacy of 0.01% atropine in slowing axial elongation and myopia progression.
Type
Publication
Clinical and Experimental Optometry, 103(2):230-232
Click the Cite button above to demo the feature to import publication metadata into your reference management software.